Admin Posted January 27, 2017 Share Posted January 27, 2017 Treatment of metastatic prostate cancer has changed recently. In the past doctors would use hormone therapy (ADT) at first, then wait until the disease was very progressed before giving chemotherapy with Taxotere (Docetaxel). The reason for the change? Professor Christopher Sweeney reported on a trial he led (CHAARTED). In CHAARTED, the researchers (an international team of medical oncologists) showed that starting BOTH chemotherapy and ADT at the beginning of treatment gave men a longer life. Members of your Executive Committee were invited to be the audience for an video interview of Christopher Sweeney and his Australian colleague, Professor Gavin Marx, by Anthony Lowe, PCFA CEO. Tony Maxwell, Alan Barlee and Nev Black and I were able to attend. (Paul Hobson had to miss out because of treatment.) Click on this sentence to see all of our videos on our YouTube channel. Note that most videos are in Playlists and you will have to click on each Playlist name to see the videos. Jim Link to comment Share on other sites More sharing options...
This topic is now archived and is closed to further replies.